FDA Charts Course for Regulating AI Used in Medical Products | McDermott Will & Emery

On March 15, 2024, four of the US Food and Drug Administration’s (FDA) medical products centers released a joint paper, titled “Artificial Intelligence & Medical Products: How CBER,...

Related Keywords

,Drug Administration ,Office Of Combination Products ,Development Of Standards ,Radiological Health ,Us Congress ,Centers Point ,Foster Collaboration To Safeguard Public Health ,Development Of Regulatory Approaches That Support Innovation ,Mcdermott Will ,Medical Products ,Working Together ,Biologics Evaluation ,Drug Evaluation ,Combination Products ,Good Machine Learning Practice Guiding Principles ,The Subject ,Collaboration To Safeguard Public ,Regulatory Approaches That Support ,Best Practices ,Medical Product Life ,Research Related ,Drug Manufacturing ,Action Plan ,Predetermined Change Control Plans ,Machine Learning Enabled Medical Devices ,